| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_acf5df4bf5276cebb1e8f52cc454544a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_922e473c1c6a15a15b239e49b868819c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6cd003bfa9c9872b20be536216740a96 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2800-107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2750-14111
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2750-14143
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2830-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2830-15 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-93
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4747 |
| filingDate |
2005-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1842e8ff71eb572ba7836f34c567f194
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e99b42ff2192bf84a4097d30cdd14b9 |
| publicationDate |
2006-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2006047250-A2 |
| titleOfInvention |
Use of apoptosis inhibiting compounds in degenerative neurological disorders |
| abstract |
The invention provides methods and compositions for localized delivery of a vector comprising a therapeutic agent to a specific region of the brain associated with a neurodegenerative diseases that is characterized by an excess buildup of intracellular protein aggregates. In particular, the invention provides methods and compositions used to deliver an adeno-associated virus vector (AAV) comprising a nucleotide sequence encoding an inhibitor of apoptosis protein (IAP) to cells in the region. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-1884530-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3668891-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10441654-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014511180-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9527904-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013175469-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103492574-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8865881-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012115980-A1 |
| priorityDate |
2004-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |